falsefalse

Inside the Clinic: Basal Cell Carcinoma Treatment Advances - Episode 8

Safety of Cemiplimab for Basal Cell Carcinoma

,

Experts review the safety and toxicity data of anti-PD-1 antibody agent cemiplimab for basal cell carcinoma treatment.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Overview of Basal Cell Carcinoma
    EP. 2: Clinical Scenario 1: A 74-Year-Old Man with Locally Advanced Infiltrative Basal Cell Carcinoma
    EP. 3: Referring Patients with Basal Cell Carcinoma to Medical Oncology
    EP. 4: Treatment Options for Locally Advanced Basal Cell Carcinoma
    EP. 5: Systemic Therapy Options for Basal Cell Carcinoma
    EP. 6: Monitoring Strategies for Basal Cell Carcinoma
    EP. 7: Clinical Scenario 2: A 66-Year-Old Woman with Locally Advanced Basal Cell Carcinoma
    Now Viewing
    EP. 8: Safety of Cemiplimab for Basal Cell Carcinoma
    EP. 9: Metastasis Patterns of Basal Cell Carcinoma
    EP. 10: Basal Cell Carcinoma Clinical Pearls

    Related Content:

    Inside the Clinic: Basal Cell Carcinoma Treatment AdvancesMelanoma & Skin Cancer
    The OncFive: Top Oncology Articles for the Week of 4/27
    China’s NMPA Approves Toripalimab in First-Line Melanoma
    Neoadjuvant Darovasertib Receives FDA Breakthrough Therapy Designation for Uveal Melanoma
    x